KR100485020B1 - 옥타하이드로-2Ｈ-피리도[1,2-ａ]피라진 화합물, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물 - Google Patents

옥타하이드로-2Ｈ-피리도[1,2-ａ]피라진 화합물, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물 Download PDF

Info

Publication number
KR100485020B1
KR100485020B1 KR10-2002-0040727A KR20020040727A KR100485020B1 KR 100485020 B1 KR100485020 B1 KR 100485020B1 KR 20020040727 A KR20020040727 A KR 20020040727A KR 100485020 B1 KR100485020 B1 KR 100485020B1
Authority
KR
South Korea
Prior art keywords
linear
branched
pyrido
octahydro
pyrazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR10-2002-0040727A
Other languages
English (en)
Korean (ko)
Other versions
KR20030007159A (ko
Inventor
솔로 골드스테인
죌라움 푸아소네뜨
장-길레 파르멘티에르
피에르 레스타지
브라이언 록하트
Original Assignee
르 라보레또레 쎄르비에르
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 르 라보레또레 쎄르비에르 filed Critical 르 라보레또레 쎄르비에르
Publication of KR20030007159A publication Critical patent/KR20030007159A/ko
Application granted granted Critical
Publication of KR100485020B1 publication Critical patent/KR100485020B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR10-2002-0040727A 2001-07-12 2002-07-12 옥타하이드로-2Ｈ-피리도[1,2-ａ]피라진 화합물, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물 Expired - Fee Related KR100485020B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR01.09260 2001-07-12
FR0109260A FR2827288B1 (fr) 2001-07-12 2001-07-12 Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
KR20030007159A KR20030007159A (ko) 2003-01-23
KR100485020B1 true KR100485020B1 (ko) 2005-04-25

Family

ID=8865405

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2002-0040727A Expired - Fee Related KR100485020B1 (ko) 2001-07-12 2002-07-12 옥타하이드로-2Ｈ-피리도[1,2-ａ]피라진 화합물, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물

Country Status (24)

Country Link
US (1) US6992085B2 (https=)
EP (1) EP1275647B1 (https=)
JP (1) JP3950018B2 (https=)
KR (1) KR100485020B1 (https=)
CN (1) CN1197863C (https=)
AR (1) AR036166A1 (https=)
AT (1) ATE254124T1 (https=)
AU (1) AU2002300094B2 (https=)
BR (1) BR0202681A (https=)
CA (1) CA2394027C (https=)
DE (1) DE60200089T2 (https=)
DK (1) DK1275647T3 (https=)
EA (1) EA005160B1 (https=)
ES (1) ES2210219T3 (https=)
FR (1) FR2827288B1 (https=)
HU (1) HUP0202282A3 (https=)
MX (1) MXPA02006699A (https=)
NO (1) NO322966B1 (https=)
NZ (1) NZ520120A (https=)
PL (1) PL355034A1 (https=)
PT (1) PT1275647E (https=)
SI (1) SI1275647T1 (https=)
TR (1) TR200302001T4 (https=)
ZA (1) ZA200205596B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089410A1 (ja) * 2003-04-03 2004-10-21 Kyowa Hakko Kogyo Co., Ltd. 神経因性疼痛の予防及び／または治療剤
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2008503560A (ja) * 2004-06-22 2008-02-07 ファイザー・プロダクツ・インク ジアザビシクロ系のヒスタミン−３受容体アンタゴニスト
RU2499795C2 (ru) * 2005-07-04 2013-11-27 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
CA2646023A1 (en) * 2006-03-10 2007-09-20 Neurogen Corporation Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
KR100871691B1 (ko) 2006-10-16 2008-12-05 삼성전자주식회사 병렬 비트 테스트 방법 및 그 방법을 사용하는 반도체메모리 장치
EP3495363B1 (en) 2016-07-28 2023-08-23 Shionogi & Co., Ltd Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect
EP3744721B1 (en) 2018-01-26 2025-07-02 Shionogi & Co., Ltd. Condensed ring compounds having dopamine d3 receptor antagonistic effect

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826839A (en) * 1985-07-19 1989-05-02 Beecham Group P.L.C. Azabicyclic benzamide derivatives
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
US5679679A (en) * 1992-09-24 1997-10-21 The United States Of America As Represented By The Department Of Health And Human Services Aralkyl diazabicycloalkane derivatives for CNS disorders
KR20010021215A (ko) * 1999-08-05 2001-03-15 데이비드 존 우드 세로토닌 수용체 리간드로서의 2,7-치환옥타히드로-1ｈ-피리도[1,2-ａ]피라진 유도체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
ES2274795T3 (es) * 1999-07-19 2007-06-01 Merck Frosst Canada Ltd. Pirazinonas, composiciones que contienen tales compuestos.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826839A (en) * 1985-07-19 1989-05-02 Beecham Group P.L.C. Azabicyclic benzamide derivatives
US5679679A (en) * 1992-09-24 1997-10-21 The United States Of America As Represented By The Department Of Health And Human Services Aralkyl diazabicycloalkane derivatives for CNS disorders
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
KR20010021215A (ko) * 1999-08-05 2001-03-15 데이비드 존 우드 세로토닌 수용체 리간드로서의 2,7-치환옥타히드로-1ｈ-피리도[1,2-ａ]피라진 유도체

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Yakugaku Zasshi. 1972 Nov;92(11):1339-49 *

Also Published As

Publication number Publication date
ES2210219T3 (es) 2004-07-01
NO20023345D0 (no) 2002-07-11
CN1397557A (zh) 2003-02-19
DK1275647T3 (da) 2004-03-15
HUP0202282A2 (hu) 2003-03-28
ATE254124T1 (de) 2003-11-15
MXPA02006699A (es) 2005-08-16
TR200302001T4 (tr) 2004-01-21
KR20030007159A (ko) 2003-01-23
NO322966B1 (no) 2006-12-18
JP2003064081A (ja) 2003-03-05
NZ520120A (en) 2004-03-26
EA200200663A1 (ru) 2003-02-27
HK1050682A1 (en) 2003-07-04
US6992085B2 (en) 2006-01-31
NO20023345L (no) 2003-01-13
SI1275647T1 (en) 2004-02-29
PL355034A1 (en) 2003-01-13
HU0202282D0 (https=) 2002-09-28
AR036166A1 (es) 2004-08-18
DE60200089D1 (de) 2003-12-18
DE60200089T2 (de) 2004-09-09
JP3950018B2 (ja) 2007-07-25
AU2002300094B2 (en) 2007-06-14
FR2827288A1 (fr) 2003-01-17
FR2827288B1 (fr) 2003-10-31
CN1197863C (zh) 2005-04-20
ZA200205596B (en) 2003-03-27
CA2394027A1 (fr) 2003-01-12
HUP0202282A3 (en) 2003-11-28
EP1275647A1 (fr) 2003-01-15
EP1275647B1 (fr) 2003-11-12
PT1275647E (pt) 2004-03-31
BR0202681A (pt) 2003-05-06
EA005160B1 (ru) 2004-12-30
US20030195216A1 (en) 2003-10-16
CA2394027C (fr) 2008-01-08

Similar Documents

Publication Publication Date Title
EP0389352B1 (fr) Dérivés fluoro-4 benzoiques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
KR100885104B1 (ko) 아자비시클릭 유도체, 이의 제조 방법 및 이를 함유하는약제 조성물
JP2000128865A (ja) 新規なジヒドロ及びテトラヒドロ―キノリン化合物、それらの製造方法ならびにそれらを含有する医薬組成物
EP0666258A1 (en) Indolylcycloaklanylamin- und Indolylcycloalkenylamine derivatives, their preparation and their use as anti-migraine agents
EP0415102B1 (en) 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-ones, a process for their preparation and their use as medicaments
HU201544B (en) Process for production of derivatives of indol-2-ons, quinoline-2-ons, benzo/bazepin-2-ons, benzimidasole-2-ons and quinasoline-2-ons 1-hydroxi-2-piperidon-alkyl and medical compositions containing these derivatives
JPH0717633B2 (ja) ヘテロアリールピペラジン抗精神病薬
KR100485020B1 (ko) 옥타하이드로-2Ｈ-피리도[1,2-ａ]피라진 화합물, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물
CZ282652B6 (cs) Indolové deriváty, způsob jejich přípravy, meziprodukty tohoto postupu, farmaceutické prostředky obsahující tyto deriváty a použití těchto derivátů
JP2665422B2 (ja) 置換された１，２，３，４−テトラヒドロシクロペント〔ｂ〕インドール、１，２，３，３ａ，４，８ａ−ヘキサヒドロシクロペント〔ｂ〕インドールおよび関連化合物
EP0129692A2 (en) Dibenzodiazepin derivatives, a process for their preparation and their use as medicaments
JPWO1998000400A1 (ja) テトラヒドロベンズインドール化合物
RU2090565C1 (ru) Рацемические или оптически активные пергидро-1h-пиридо(1,2-а) пиразины или их фармацевтически приемлемые соли и способ их получения
CS29991A2 (en) Tricyclo-cyclic amines, method of their preparation and pharmaceutical preparations that them contain
CA2612109A1 (en) Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists
EP0463596A1 (en) Cerebral function enhancing pyrimidinyl derivatives
JP2001520224A (ja) ２−置換１，２−ベンジイソチアゾール誘導体およびそのセロトニン拮抗薬（５−ｈｔ１ａ、５−ｈｔ１ｂ、５−ｈｔ１ｄ）としての使用
JPH07165754A (ja) ヘテロアリールピペリジン、その製造方法およびそれを含有する医薬組成物
JP3709203B2 (ja) ５−ｈｔ１ａレセプターに対して親和性をもつ三環式化合物
KR20070097419A (ko) 아릴피페라진 유도체 및 5-에취티1에이 수용체 리간드로서그 사용
HU197329B (en) Process for producing pyrimido-indol derivatives and pharmaceutical compositions containing them
CS268187B2 (en) Method of new tetrahydrobenzothiazolo-quinolines production

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20080213

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20090415

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20090415